123 related articles for article (PubMed ID: 15846092)
1. Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin.
Oridate N; Kim HJ; Xu X; Lotan R
Cancer Biol Ther; 2005 Mar; 4(3):318-23. PubMed ID: 15846092
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencing.
Iizuka S; Oridate N; Nashimoto M; Fukuda S; Tamura M
PLoS One; 2014; 9(12):e114121. PubMed ID: 25437003
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.
Nozawa H; Tadakuma T; Ono T; Sato M; Hiroi S; Masumoto K; Sato Y
Cancer Sci; 2006 Oct; 97(10):1115-24. PubMed ID: 16984384
[TBL] [Abstract][Full Text] [Related]
4. Sodium arsenite-induced inhibition of eukaryotic translation initiation factor 4E (eIF4E) results in cytotoxicity and cell death.
Othumpangat S; Kashon M; Joseph P
Mol Cell Biochem; 2005 Nov; 279(1-2):123-31. PubMed ID: 16283521
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
Kothari V; Mulherkar R
Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
[TBL] [Abstract][Full Text] [Related]
6. 5'-Cap‒Dependent Translation as a Potent Therapeutic Target for Lethal Human Squamous Cell Carcinoma.
Srivastava RK; Khan J; Arumugam A; Muzaffar S; Guroji P; Gorbatyuk MS; Elmets CA; Slominski AT; Mukhtar MS; Athar M
J Invest Dermatol; 2021 Apr; 141(4):742-753.e10. PubMed ID: 32971126
[TBL] [Abstract][Full Text] [Related]
7. Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma.
Nakashima T; Clayman GL
Arch Otolaryngol Head Neck Surg; 2000 Aug; 126(8):957-61. PubMed ID: 10922227
[TBL] [Abstract][Full Text] [Related]
8. Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line.
DeFatta RJ; Nathan CO; De Benedetti A
Laryngoscope; 2000 Jun; 110(6):928-33. PubMed ID: 10852506
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C
Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265
[TBL] [Abstract][Full Text] [Related]
10. [In vitro gene silencing by siRNA of cyclin D1 on tongue squamous cell carcinoma cell line resistant to cisplatin].
Zhou XJ; Zhang ZY; Zhang P; Pan HY; Chen WT; Ye DX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov; 41(11):646-9. PubMed ID: 17331354
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth.
Liang S; Guo R; Zhang Z; Liu D; Xu H; Xu Z; Wang X; Yang L
Oncol Rep; 2013 Jun; 29(6):2422-30. PubMed ID: 23588929
[TBL] [Abstract][Full Text] [Related]
14. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
15. CCND1 amplification predicts sensitivity to chemotherapy and chemoradiotherapy in head and neck squamous cell carcinoma.
Ishiguro R; Fujii M; Yamashita T; Tashiro M; Tomita T; Ogawa K; Kameyama K
Anticancer Res; 2003; 23(6D):5213-20. PubMed ID: 14981992
[TBL] [Abstract][Full Text] [Related]
16. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
Wang MB; Yip HT; Srivatsan ES
Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
[TBL] [Abstract][Full Text] [Related]
17. The effect of cyclin D1 overexpression in human head and neck cancer cells.
Nakashima T; Kuratomi Y; Yasumatsu R; Masuda M; Koike K; Umezaki T; Clayman GL; Nakagawa T; Komune S
Eur Arch Otorhinolaryngol; 2005 May; 262(5):379-83. PubMed ID: 15368064
[TBL] [Abstract][Full Text] [Related]
18. Targeting translation: eIF4E as an emerging anticancer drug target.
Lu C; Makala L; Wu D; Cai Y
Expert Rev Mol Med; 2016 Jan; 18():e2. PubMed ID: 26775675
[TBL] [Abstract][Full Text] [Related]
19. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
20. eIF4E expression in tumors: its possible role in progression of malignancies.
De Benedetti A; Harris AL
Int J Biochem Cell Biol; 1999 Jan; 31(1):59-72. PubMed ID: 10216944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]